A detailed history of Benin Management Corp transactions in Eli Lilly & CO stock. As of the latest transaction made, Benin Management Corp holds 759 shares of LLY stock, worth $694,158. This represents 0.19% of its overall portfolio holdings.

Number of Shares
759
Previous 754 0.66%
Holding current value
$694,158
Previous $439,000 34.4%
% of portfolio
0.19%
Previous 0.15%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 15, 2024

BUY
$592.2 - $792.28 $2,961 - $3,961
5 Added 0.66%
759 $590,000
Q3 2023

Oct 19, 2023

SELL
$434.7 - $599.3 $21,735 - $29,964
-50 Reduced 6.22%
754 $404,000
Q2 2023

Jul 24, 2023

SELL
$350.74 - $468.98 $33,671 - $45,022
-96 Reduced 10.67%
804 $377,000
Q2 2021

Jul 21, 2021

BUY
$180.55 - $233.54 $162,495 - $210,186
900 New
900 $207,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $869B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Benin Management Corp Portfolio

Follow Benin Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Benin Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Benin Management Corp with notifications on news.